Cita APA

Passos-Bueno, M. R. (2001). A polymorphism in endostatin, an angiogenesis inhibitor, predisposes for the development of prostatic adenocarcinoma.

Citación estilo Chicago

Passos-Bueno, Maria Rita. A Polymorphism in Endostatin, an Angiogenesis Inhibitor, Predisposes for the Development of Prostatic Adenocarcinoma. 2001.

Cita MLA

Passos-Bueno, Maria Rita. A Polymorphism in Endostatin, an Angiogenesis Inhibitor, Predisposes for the Development of Prostatic Adenocarcinoma. 2001.

Precaución: Estas citas no son 100% exactas.